Agio Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1992.
1992 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Agio Pharmaceuticals Limited

Agio Pharmaceuticals Limited, a active public limited company, was established on 24 January 1992 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1992PLC065031. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.18 Cr.

It upholds a compliant status. Employing 343 professional, Its leadership includes Mahendra Kumar Kumawat (Whole-Time Director), Raghav Sanjay Ruia (Whole-Time Director), Madhusudan Govindprasad Ruia (Managing Director). Past directors included Sneha Ahuja, Ravikant F Sharma, Pankaj Nandkishor Chandak. It holds ₹75.02 Cr open charges and ₹205.08 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safed Pool,, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1992PLC065031

  • Registration Number

    065031

  • Incorporation Date

    24 January 1992

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹5.18 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 5.18 Cr
  • Company Age 34 Year, 23 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 75.02 Cr
  • Satisfied Charges ₹ 205.08 Cr
  • Revenue Growth **** 66.15%
  • Profit Growth **** 1772.06%
  • Ebitda **** 278.54%
  • Net Worth 28.91%
  • Total Assets **** 3.47%
Company report

Agio Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Agio Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Agio Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Mahendra Kumar Kumawat Whole-Time Director 09 Sep 2020 Current
Raghav Sanjay Ruia Whole-Time Director 04 Oct 2019 Current
Madhusudan Govindprasad Ruia Managing Director 24 Jan 1992 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Whole-Time Director 04 Jul 2013 Past
Pramod Abcsdd Whole-Time Director 09 Oct 2019 Past
Pramod Abcsdd Whole-Time Director 17 Sep 2020 Past
Pramod Abcsdd Director 07 Dec 2011 Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Agio Pharmaceuticals.

Agio Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.15% increase. The company also saw a substantial improvement in profitability, with a 1772.06% increase in profit. The company's net worth Soared by an impressive increase of 28.91%.

Agio Pharmaceuticals revenue growth over time
Agio Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 66.15%
*******
*******
*******
*******
Revenue from Operations
*******
 65.98%
*******
*******
*******
*******
Total Assets
*******
 3.47%
*******
*******
*******
*******
Profit or Loss
*******
 1772.06%
*******
*******
*******
*******
Net Worth
*******
 28.91%
*******
*******
*******
*******
EBITDA
*******
 278.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Agio Pharmaceuticals?

In 2022, Agio Pharmaceuticals had a promoter holding of 94.86% and a public holding of 5.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹750,155,950.00

Satisfied Charges

₹2,050,800,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 65.69 Cr
  • Others : 8.10 Cr
  • Axis Bank Limited : 0.80 Cr
  • Hdfc Bank Limited : 0.43 Cr
Latest Charge Details
Date Lender Amount Status
13 Oct 2025 Hdfc Bank Limited ₹4.30 M Open
28 Nov 2024 Others ₹5.80 M Open
18 Mar 2024 Sbicap Trustee Company Limited ₹65.69 Cr Open
10 Nov 2023 Others ₹5.10 M Open
21 Jul 2023 Axis Bank Limited ₹8.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Agio Pharmaceuticals?

Agio Pharmaceuticals has a workforce of 343 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Agio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agio Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Agio Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.43 Cr with Charge ID 101191467 was registered on 13 Oct 2025. was completed.

  • Annual General Meeting

    The activity Agio Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Agio Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.58 Cr with Charge ID 101019912 was registered on 28 Nov 2024. was documented.

  • Charges

    The activity A charge with Sbicap Trustee Company Limited of Rs. 65.69 Cr registered on 18 Mar 2024 with Charge ID 100897901 was modified on 24 Jul 2024. was completed.

  • Charges

    Progress on A charge with Others of Rs. 0.84 Cr registered on 23 Mar 2011 with Charge ID 10286381 was modified on 29 May 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Agio Pharmaceuticals Limited?

The CIN of Agio Pharmaceuticals Limited is U24239MH1992PLC065031.

Where is Agio Pharmaceuticals Limited headquartered?

Agio Pharmaceuticals Limited is headquartered at A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safed Pool,, Mumbai, Maharashtra, 400072.

When was Agio Pharmaceuticals Limited incorporated?

Agio Pharmaceuticals Limited was incorporated on 24 January 1992.

Who are the current directors of Agio Pharmaceuticals Limited?

The current directors of Agio Pharmaceuticals Limited are

What is the primary industry of Agio Pharmaceuticals Limited?

The primary industry of Agio Pharmaceuticals Limited is Manufacturing.

Is Agio Pharmaceuticals Limited a listed company?

Agio Pharmaceuticals Limited is unlisted.

What is the capital structure of Agio Pharmaceuticals Limited?

The authorized capital of Agio Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹5.18 Cr.

What is the compliance status of Agio Pharmaceuticals Limited?

The compliance status of Agio Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available